Drug
Pert Ijs Plus Trastuzumab
Pert Ijs Plus Trastuzumab: highest development phase Phase 3, developed by Biocon. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biocon
Trials
| Drug | Phase | Indication |
|---|---|---|
| PERT-IJS plus trastuzumab, carboplatin and docetaxel NCT06038539 | Phase 3 | HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients |
Latest
No recent events.
Follow Pert Ijs Plus Trastuzumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.